McKesson is paying $2.49 billion in cash for a controlling interest in Florida Cancer Specialists’ management services organization
Acquisition to Enhance McKesson’s Oncology Platform
June 7, 2025
- Journalists Recap State of NIH Cancer Research and Abortion Law’s Effect on Clinical Decisions
- Serve You Rx Adds 2 Stelara Biosimilars to Formulary to Help Patients Save Costs
- Key readings to help you evaluate a major change to US drug pricing policy
- Tribes Question Kennedy’s Promise To Protect Them From Health Cuts
Headlines
